ArticleThe Lancet regional health. Western Pacific2023

A simple, feasible, efficient and safe treatment strategy of sofosbuvir/velpatasvir for chronic HCV/HIV-1 coinfected patients regardless of HCV genotypes: a multicenter, open-label study in China.

Weiyin Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.